Understanding immunE-related toXicities by multifACeT Profiling
ConditionOncology
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRoyal Marsden NHS Foundation Trust
About this trial
A prospective observational cohort study of patients undergoing CPI therapy in which translational research is the fundamental aspect of the study.
Eligibility criteria
Qualifiers
Written informed consent
Age 18 years or older
Confirmed diagnosis of any form of solid malignancy with a clinical indication and appropriate treatment plan to commence immune checkpoint inhibitor therapy
Disqualifiers
Medical or psychological condition that would preclude informed consent
Planned participation in a drug trial receiving investigational agents
Subjects who have previously commenced immune checkpoint inhibitor therapy prior to study entry.
Subjects unable to comply with the study or sample schedule.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov